Autologous Adipose Cells Therapy

Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age21-80
SponsorCERM INC.

About this trial

Autologous Adipose Cell Therapy is a series of process designated to address the demerits of the traditional autologous fat grafting and dermal fillers, while enhancing the versatility and aesthetic outcomes. In this study, the goal is to evaluate the safety and efficacy of Autologous Adipose cell Therapy for skin rejuvenation and hair improvement in human application.

Eligibility criteria

Qualifiers

Outpatients who express interest in skin rejuvenation, and/or who are experiencing skin conditions, such as winkles, fine lines, loss of skin elasticity, skin pigmentation, scarring.

Outpatients who are experiencing hair loss or hair thinning

Provision of signed and dated informed consent form

Clearly stated willingness to comply with all the procedures of the study and availability of the study

Disqualifiers

Pregnancy or lactation

Known allergic reaction to components of cell culture media

Chronic disease , e.g. cardiovascular disease, diabetes, chronic kidney disease, seizures

Chronic infections, e.g. skin fungi infection, psoriasis

Trial design

Treatments tested in this trial

  • Autologous Adipose Cells Therapy

Treatment groups

40 Participants
are divided into 1 treatment group

Sponsors and collaborators